Novavax Logo

Novavax

Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Using innovative proprietary recombinant nanoparticle vaccine technology, we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. Our vaccine candidates are genetically engineered three-dimensional nanostructures that incorporate recombinant proteins critical to disease pathogenesis.

NEWS ARTICLES

National Academy of Medicine: “An effective pandemic preparedness and response system is possible”

STAT News: “Push to double up on Covid booster and flu shot may have a downside, experts caution”

U.S. News: “Another Reason to Get the Flu Shot: Lowered Risk for Stroke”